Role of mitochondrial fusion in doxorubicin-induced cardiotoxicity

doi:10.16352/j.issn.1001-6325.2025.01.0126

Abstract

Abstract: Adriamycin is a widely used anti-tumor drug. Targeting mitochondrial fusion proteins/mitofusion 1/2(MFN1/2) and nuclear factor-erythroid 2-related factor 2(NRF2) can up-regulate the expression of mitochondrial fusion protein through PKCε/Stat3/MFN2, SIRT1/MFN2, AMPK/NRF2 and other signaling pathways, promote mitochondrial fusion, maintain kinetic balance and protect mitochondrial function, reduce myocardial cell apoptosis and reduce cardiac toxicity. Understanding the regulatory role and mechanism of mitochondrial fusion in doxorubicin-induced cardio toxicity will provide new strategies for the prevention and treatment of diseases.

Key words: doxorubicin, mitochondrial fusion, cardiotoxicity, mitofusin(MFN1/2), nuclear factor-erythroid 2-related factor 2(NRF2)

CLC Number:

R541.9

WANG Yuqi, WANG Xinyu, LUO Haowen, LU Zhaoxin, ZHAO Yiwei, CHANG Pan. Role of mitochondrial fusion in doxorubicin-induced cardiotoxicity[J]. Basic & Clinical Medicine, 2025, 45(1): 126-129.

References

[1] Hazim A, Nhola LF, Kailash V, et al. Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide[J]. Eur Heart J Open,2023,4:1-10.
[2] Humeniuk E, Adamczuk G, Kubik J, et al. Cardioprotective effect of centaurea castriferrei borbás & waisb extract against doxorubicin-induced cardiotoxicity in H9c2 cells[J]. Molecules, 2023,28:420. doi: 10.3390/molecules28010420.
[3] Zhuang X, Sun X, Zhou H, et al. Klotho attenuated doxorubicin-induced cardiomyopathy by alleviating dynamin-related protein 1-mediated mitochondrial dysfunction[J]. Mech Ageing Dev, 2021,195:111442. doi: 10.1016/j.mad.2021.111442.
[4] 李梦婕,柯本,龙脉,等.线粒体融合蛋白Mfn2在糖尿病肾病中作用的研究进展[J].基础医学与临床,2021,41:1823-1827.
[5] 胡欢,李萍,程晓曙.线粒体融合-分裂与心力衰竭[J].基础医学与临床,2018,38:553-556.
[6] Labbé K, Mookerjee S, Le Vasseur M,et al. The modified mitochondrial outer membrane carrier MTCH2 links mitochondrial fusion to lipogenesis[J]. J Cell Biol,2021, 220 e202103122. doi: 10.1083/jcb.202103122.
[7] Zhang Q, Zhang Y, Xie B, et al. Resveratrol activation of SIRT1/MFN2 can improve mitochondria function, alleviating doxorubicin-induced myocardial injury[J].Cancer Innov, 2023,2:253-264.
[8] Brandão SR, Reis-Mendes A, Neuparth MJ, et al. The metabolic fingerprint of doxorubicin-induced cardiotoxicity in male CD-1 mice fades away with time while autophagy increases[J]. Pharmaceuticals (Basel), 2023,16:1613.doi: 10.3390/ph16111613.
[9] He J, Hou L, Liu Q, et al. Irisin links claudin-5 preservation and mfn2-mediated mitochondrial dynamics to resist doxorubicin-induced cardiac endothelial damage[J]. Biochem Biophys Res Commun, 2024,696:149501.doi: 10.1016/j.bbrc.2024.149501.
[10] Ding M, Shi R, Cheng S, et al. Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch[J].Redox Biol, 2022,52:102311.doi: 10.1016/j.redox.2022.102311.
[11] Ding M, Shi R, Fu F, et al. Paeonol protects against doxorubicin-induced cardiotoxicity by promoting Mfn2-mediated mitochondrial fusion through activating the PKCε-Stat3 pathway[J]. J Adv Res, 2023,47:151-162.
[12] Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene[J].Proc Natl Acad Sci USA,1996,93:14960-5. doi: 10.1073/pnas.93.25.14960.
[13] Zhuo C, Xin J, Huang W, et al. Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms[J].Toxicology, 2023,494:153597.doi: 10.1016/j.tox.2023.153597.
[14] Zhang HJ, Fu Y, Zhang H, et al. Sophocarpine alleviates doxorubicin-induced heart injury by suppressing oxidative stress and apoptosis[J]. Sci Rep, 2024,14:428.doi: 10.1038/s41598-023-51083-3.
[15] Zheng M, Bai Y, Sun X, et al. Resveratrol reestablishes mitochondrial quality control in myocardial ischemia/reperfusion injury through Sirt1/Sirt3-Mfn2-Parkin-PGC-1α pathway[J]. Molecules,2022,27:5545. doi: 10.3390/molecules27175545.
[16] Fry M Y, Navarro P P, Hakim P, et al. In situ architecture of Opa1-dependent mitochondrial cristae remodeling[J]. The EMBO Journal, 2024,2024:1-23.
[17] Ehses S, Raschke I, Mancuso G, et al. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1[J]. J Cell Biol,2009,187:1023-1036.
[18] Li L, Li J, Wang Q, et al. Shenmai injection protects against doxorubicin-induced cardiotoxicity via maintaining mitochondrial homeostasis[J]. Front Pharmacol,2020,11:815. doi: 10.3389/fphar.2020.00815.
[19] Maneechote C, Khuanjing T, Ongnok B, et al. Promoting mitochondrial fusion in doxorubicin-induced cardiotoxi-city: a novel therapeutic target for cardioprotection[J].Clin Sci (Lond),2022,136:841-860.
[20] Arinno A, Maneechote C, Khuanjing T, et al.Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics[J]. Biochemical Pharmacology, 2021, 192: 114743. doi: 10.1016/j.bcp.2021.114743.
[21] Hu B, Zhen D, Bai M, et al. Ethanol extracts of Rhaponticum uniflorum (L.) DC flowers attenuate doxorubicin-induced cardiotoxicity via alleviating apoptosis and regulating mitochondrial dynamics in H9c2 cells[J].J Ethnopharmacol, 2022, 288:114936. doi: 10.1016/j.jep.2021.114936.
[22] Zhou W, Ouyang J, Hu N, et al. Flavonoids from hippophae rhamnoides Linn. Revert doxorubicin-induced cardiotoxicity through inhibition of mitochondrial dysfunction in H9c2 cardiomyoblasts in vitro[J]. Int J Mol Sci, 2023,24:3174. doi:10.3390/ijms24043174.
[23] Duan J, Liu X, Shen S, et al. Trophoblast stem-cell-derived exosomes alleviate cardiotoxicity of doxorubicin via improving Mfn2-mediated mitochondrial fusion[J].Cardiovasc Toxicol, 2023, 23:23-31.